戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 -transduced HEK293T cells required an intact immunoreceptor tyrosine-based inhibitory motif.
2 ts extracellular domain or signaling via its immunoreceptor tyrosine-based inhibitory motif.
3 osine phosphatase 1 (SHP-1) to a cytoplasmic immunoreceptor tyrosine-based inhibitory motif.
4  (SHIP) to the phosphorylated Fc gamma RIIB1 immunoreceptor tyrosine-based inhibitory motif.
5 pends on tyrosine residues restricted to the immunoreceptor tyrosine-based inhibitory motif.
6 ther region containing a motif similar to an immunoreceptor tyrosine-based inhibitory motif.
7 g cytoplasmic tail containing four potential immunoreceptor tyrosine-based inhibitory motifs.
8  domain superfamily protein with cytoplasmic immunoreceptor tyrosine-based inhibitory motifs.
9 e cellular activation pathways via cytosolic immunoreceptor tyrosine-based inhibitory motifs.
10 ulin domain-containing glycoprotein with two immunoreceptor tyrosine-based inhibitory motifs.
11 dhesive and signaling properties mediated by immunoreceptor tyrosine-based inhibitory motifs.
12 ulate cellular responses through cytoplasmic immunoreceptor tyrosine-based inhibitory motifs.
13 ly cell surface protein containing a pair of immunoreceptor tyrosine-based inhibitory motifs.
14 identity to any known protein except for two immunoreceptor tyrosine-based inhibitory motifs.
15 asmic domain of LIR-1 contains four putative immunoreceptor tyrosine-based inhibitory motifs.
16                             PD-1 contains an immunoreceptor tyrosine-based inhibitory motif and mice
17  RIIb, a low affinity receptor containing an immunoreceptor tyrosine-based inhibitory motif and whose
18 ptor Fcgamma receptor IIB (FcgammaRIIB), its immunoreceptor tyrosine-based inhibitory motif, and SH2
19 esidues, including two that lie in consensus immunoreceptor tyrosine-based inhibitory motifs, and we
20 t Tyr(233) and Tyr(263), each embedded in an immunoreceptor tyrosine-based inhibitory motif, are resp
21  Our data further support the involvement of immunoreceptor tyrosine-based inhibitory motifs as cruci
22 ory counterparts, Ly49D and H do not contain immunoreceptor tyrosine-based inhibitory motifs but asso
23                                 We found the immunoreceptor tyrosine-based inhibitory motif-containin
24 hibit T cell responses via engagement of the immunoreceptor tyrosine-based inhibitory motif-containin
25                             FcgammaRIIb, the immunoreceptor tyrosine-based inhibitory motif-containin
26                                          The immunoreceptor tyrosine-based inhibitory motif-containin
27 erived from umbilical cord blood express the immunoreceptor tyrosine-based inhibitory motif-containin
28     Molecular studies revealed that both the immunoreceptor tyrosine-based inhibitory motif-containin
29                                           An immunoreceptor tyrosine-based inhibitory motif-containin
30 nsmembrane region, and in most instances, an immunoreceptor tyrosine-based inhibitory motif-containin
31 ppressive receptor T-cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain (T
32 , required both tyrosine residues within the immunoreceptor tyrosine-based inhibitory motif domains o
33  is further evidenced by the conservation of immunoreceptor tyrosine-based inhibitory motifs during t
34  cells that express this novel member of the immunoreceptor tyrosine-based inhibitory motif family of
35 ain of Ly-49D does not contain the V/Ix-YxxL immunoreceptor tyrosine-based inhibitory motif found in
36 h is the most abundant, contains a consensus immunoreceptor tyrosine-based inhibitory motif in its cy
37 latelet immunoglobulin receptor that has two immunoreceptor tyrosine-based inhibitory motifs in its c
38 ransduction by receptor tyrosine kinases via immunoreceptor tyrosine-based inhibitory motifs in the c
39                Recent advances indicate that immunoreceptor tyrosine-based inhibitory motifs in the c
40 bitory receptors possess ITIM sequences (for immunoreceptor tyrosine-based inhibitory motifs) in thei
41 mbrane segment and cytoplasmic tail with two immunoreceptor tyrosine-based inhibitory motifs, indicat
42 b is an inhibitory platelet receptor with an immunoreceptor tyrosine-based inhibitory motif (ITIM) an
43                                 CD300a is an immunoreceptor tyrosine-based inhibitory motif (ITIM) co
44 44 also contains a sequence that matches the immunoreceptor tyrosine-based inhibitory motif (ITIM) co
45 PECAM-1), a homophilic-binding member of the immunoreceptor tyrosine-based inhibitory motif (ITIM) fa
46  Fcgamma receptor IIb (FcgammaRIIb), with an immunoreceptor tyrosine-based inhibitory motif (ITIM) in
47 rosine-containing sequences derived from the immunoreceptor tyrosine-based inhibitory motif (ITIM) kn
48 ock-in mouse with a targeted mutation in the immunoreceptor tyrosine-based inhibitory motif (ITIM) of
49 RIIb on the surface of B cells, resulting in immunoreceptor tyrosine-based inhibitory motif (ITIM) ph
50      We show that vGPCR contains a bona fide immunoreceptor tyrosine-based inhibitory motif (ITIM) th
51   The PECAM-1 cytoplasmic domain contains an immunoreceptor tyrosine-based inhibitory motif (ITIM) th
52                  CD33 contains a cytoplasmic immunoreceptor tyrosine-based inhibitory motif (ITIM), w
53             DCAL-2 is a CLR with a cytosolic immunoreceptor tyrosine-based inhibitory motif (ITIM), w
54 sm involving tyrosine phosphorylation of the immunoreceptor tyrosine-based inhibitory motif (ITIM), w
55 press full-length transcripts for gp49B1, an immunoreceptor tyrosine-based inhibitory motif (ITIM)-co
56                                              Immunoreceptor tyrosine-based inhibitory motif (ITIM)-co
57                   Finally, activation of the immunoreceptor tyrosine-based inhibitory motif (ITIM)-co
58 2 blocks activation mediated by Ly-49D in an immunoreceptor tyrosine-based inhibitory motif (ITIM)-de
59 I signaling through a previously undescribed immunoreceptor tyrosine-based inhibitory motif (ITIM)-li
60 brane domain and a cytoplasmic tail with two immunoreceptor tyrosine-based inhibitory motif (ITIM)-li
61     The FDF03 cytoplasmic tail contained two immunoreceptor tyrosine-based inhibitory motif (ITIM)-li
62 g receptors, but also contains a cytoplasmic immunoreceptor tyrosine-based inhibitory motif (ITIM).
63 ntaining two tyrosines, one within a typical immunoreceptor tyrosine-based inhibitory motif (ITIM).
64                                              Immunoreceptor tyrosine-based inhibitory motifs (ITIM) h
65 motif (ITAM)-like sequence and two consensus immunoreceptor tyrosine-based inhibitory motifs (ITIM) i
66 9D and Ly-49H, two Ly-49 molecules that lack immunoreceptor tyrosine-based inhibitory motifs (ITIM) i
67 ivation motif [ITAM] and FcgammaRIIb with an immunoreceptor tyrosine-based inhibitory motif [ITIM]).
68 lagen tail trigger phosphorylation of LAIR-1 immunoreceptor tyrosine-based inhibitory motifs (ITIMs)
69 oglobulin-like (IgL) domains and cytoplasmic immunoreceptor tyrosine-based inhibitory motifs (ITIMs)
70 ivity to LM infection, while mutation of its immunoreceptor tyrosine-based inhibitory motifs (ITIMs)
71 o SHP-1 and SHP-2 after phosphorylation of 2 immunoreceptor tyrosine-based inhibitory motifs (ITIMs)
72 pid rafts of PBMCs, is phosphorylated on the immunoreceptor tyrosine-based inhibitory motifs (ITIMs)
73                         The CD33 cytoplasmic immunoreceptor tyrosine-based inhibitory motifs (ITIMs)
74 rotein tyrosine phosphatase-1 (SHP-1) to two immunoreceptor tyrosine-based inhibitory motifs (ITIMs)
75 as recently been shown to contain functional immunoreceptor tyrosine-based inhibitory motifs (ITIMs)
76                 Although CD22 contains three immunoreceptor tyrosine-based inhibitory motifs (ITIMs),
77 and SHP-2, to two phosphorylated cytoplasmic immunoreceptor tyrosine-based inhibitory motifs (ITIMs).
78 osine phosphatase (SHP)-1, to phosphorylated immunoreceptor tyrosine-based inhibitory motifs (ITIMs).
79 ntracellular domain contains three potential immunoreceptor tyrosine-based inhibitory motifs (ITIMs).
80 vation motifs (ITAMs) and those that contain immunoreceptor tyrosine-based inhibitory motifs (ITIMs).
81 discovered that we have named Ly49O, and one immunoreceptor tyrosine-based inhibitory motif-lacking,
82 inhibitory motif-containing gp49B as well as immunoreceptor tyrosine-based inhibitory motif-less gp49
83 containing two tyrosine residues embodied in immunoreceptor tyrosine-based inhibitory motif-like moti
84 asmic domains containing two, three, or four immunoreceptor tyrosine-based inhibitory motif-like moti
85 those with a short cytoplasmic domain and no immunoreceptor tyrosine-based inhibitory motif-like moti
86 he adhesion-dependent phosphorylation of the immunoreceptor tyrosine-based inhibitory motif of the in
87 rosine to phenylalanine in either of the two immunoreceptor tyrosine-based inhibitory motifs of the g
88  an inhibitory member containing cytoplasmic immunoreceptor tyrosine-based inhibitory motifs, on thes
89 a long cytoplasmic (cyt) tail containing two immunoreceptor tyrosine-based inhibitory motifs or a uni
90 vitro to modulate cellular responses through immunoreceptor tyrosine-based inhibitory motifs or throu
91         CRP-induced increases in FcgammaRIIB immunoreceptor tyrosine-based inhibitory motif phosphory
92 ing properties, the latter being mediated by immunoreceptor tyrosine-based inhibitory motifs present
93 tation of the conserved tyrosines in the two immunoreceptor tyrosine-based inhibitory motifs prevents
94 esults in phosphorylation of the cytoplasmic immunoreceptor tyrosine-based inhibitory motifs, resulti
95 tion of the human IL-4 receptor alpha in the immunoreceptor tyrosine-based inhibitory motif sequence
96 49 family members have been shown to have an immunoreceptor tyrosine-based inhibitory motif that is r
97 riable domain, a transmembrane domain and an immunoreceptor tyrosine-based inhibitory motif that was
98 ry NK cell receptors for MHC class I express immunoreceptor tyrosine-based inhibitory motifs that rec
99                                              Immunoreceptor tyrosine-based inhibitory motifs that tra
100 ignal is consistent with the presence of two immunoreceptor tyrosine-based inhibitory motifs (V/LXYXX
101 rosine 241 and 263 embedded in the consensus immunoreceptor tyrosine-based inhibitory motifs VIYAQL a
102 ion of PIR-B is mediated via its cytoplasmic immunoreceptor tyrosine-based inhibitory motifs, whereas
103  a conserved cytoplasmic sequence motif, the immunoreceptor tyrosine-based inhibitory motif, which fu
104 itory receptor family, contains a functional immunoreceptor tyrosine-based inhibitory motif within it
105 mains within its extracellular domain and an immunoreceptor tyrosine-based inhibitory motif within it

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top